Literature DB >> 2550815

A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line.

S K Nordeen1, B Kühnel, J Lawler-Heavner, D A Barber, D P Edwards.   

Abstract

Progesterone receptor-containing T47D human breast cancer cells are responsive to progestins but fail to respond to other steroid hormones, in particular dexamethasone, because they have no measurable levels of receptors for estrogens, androgens, or glucocorticoids. To quantitatively study dual responsiveness of the mouse mammary tumor virus (MMTV) promoter to progestins and glucocorticoids, we have stably transfected T47D cells with a glucocorticoid receptor (GR) expression vector. A cloned derivative (A1-2) was isolated that expresses a normal, full length GR, as assessed by steroid binding and Western immunoblot with a monoclonal anti-GR antibody. Moreover, GR is expressed at levels (80,000-100,000 molecules per cell) comparable to the high levels of endogenous progesterone receptor (200,000 molecules per cell). In A1-2 cells transiently transfected with an MMTV-chloramphenicol acetyl transferase reporter gene, induction by glucocorticoid was substantially greater (5-fold) than induction mediated by progestins. These results suggest that glucocorticoids may be the primary regulator of MMTV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550815     DOI: 10.1210/mend-3-8-1270

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.

Authors:  Christopher D Chien; Alexander Kirilyuk; Jordan V Li; Wentao Zhang; Tyler Lahusen; Marcel O Schmidt; Annabell S Oh; Anton Wellstein; Anna T Riegel
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

Authors:  Nicole M Kretzer; Milu T Cherian; Chengjian Mao; Irene O Aninye; Philip D Reynolds; Rachel Schiff; Paul J Hergenrother; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  8-alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists.

Authors:  Irene O Aninye; Kenneth C Berg; Andy R Mollo; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
Journal:  Steroids       Date:  2012-03-06       Impact factor: 2.668

4.  Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.

Authors:  Steven K Nordeen; Betty J Bona; David N Jones; James R Lambert; Twila A Jackson
Journal:  Horm Cancer       Date:  2013-07-09       Impact factor: 3.869

5.  Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin.

Authors:  B J Deroo; T K Archer
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

6.  Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly.

Authors:  Sayura Aoyagi; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272

7.  Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.

Authors:  Suzanne E Wardell; Viroj Boonyaratanakornkit; James S Adelman; Ami Aronheim; Dean P Edwards
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.

Authors:  Chengjian Mao; Nicole M Patterson; Milu T Cherian; Irene O Aninye; Chen Zhang; Jamie Bonéy Montoya; Jingwei Cheng; Karson S Putt; Paul J Hergenrother; Elizabeth M Wilson; Ann M Nardulli; Steven K Nordeen; David J Shapiro
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

9.  The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.

Authors:  C A Beck; N L Weigel; M L Moyer; S K Nordeen; D P Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.

Authors:  D P Edwards; N L Weigel; S K Nordeen; C A Beck
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.